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Abstract 
Chronic wounds, including pressure ulcers, foot ulcers and venous leg ulcers have a 
detrimental impact on the health and well-being of an estimated 2% of people in the UK.   
Chronic wounds are normally colonised by bacteria and in some instances bacterial load 
increases sufficiently for infection to ensue.  Once a chronic wound becomes infected it is 
difficult to resolve and a combination of continuous inflammation and bacterial proliferation 
makes these wounds difficult to manage.  A state of prolonged inflammation can occur as a 
result of impaired homeostatic pathways which are exacerbated by bacterial growth.  
Chronic, infected wounds can persist for many months or even years, sometimes requiring 
surgical intervention in the form of regular debridement or amputation when other 
strategies such as antimicrobial treatments fail.  The complex relationships between both 
oral microbiota and the host have been extensively characterised, including the shift from 
health to disease, and has allowed for the development of numerous control strategies.  
This knowledge combined with contemporary studies of chronic infected wounds can be 
used to develop an understanding of the relationship between the host and microorganism 
in the chronic wound environment.  Such information has the potential to inform wound 
management including strategies to control infection and promote wound healing.  
 
 
 
 
 
Introduction 
In developed countries, it has been estimated that 1 to 2% of the population will 
experience a chronic wound during their lifetime (Gottrup, 2004).  Chronic wounds are 
defined as those that fail to heal in a predictable or timely manner (less than three months), 
being instead confined to one or more phases of wound healing (Werdin et al., 2009).    
Arrested healing perpetuates an ideal environment for microbial growth and all chronic 
wounds are colonised with bacteria; a state of infection occurs only when the microbial load 
exceeds critical colonisation (~1x106 CFU per gram tissue) (Kingsley, 2001).   
 Traditional culture and contemporary molecular diagnostics have identified diverse 
microbiota from chronic infected wounds, many of which are of endogenous origin (Singer 
and Clark, 1999).  Most commonly isolated are Staphylococcus aureus and Pseudomonas 
aeruginosa (>90% and 80%, respectively) followed by Enterococcus faecalis, coagulase 
negative staphylococci and Proteus spp.  Other common wound isolates include members of 
the genera Enterobacter, Streptococcus, Citrobacter, Morganella and Corynebacteria (Dowd 
et al., 2008, Frank et al., 2009, Wolcott et al., 2009, Wolcott et al., 2015).   
 Treatment of chronic infected wounds remains challenging with numerous strategies 
employed, including topical antimicrobial intervention, physical cleaning of the wound or 
surgical debridement (Kirshen et al., 2006, Jones et al., 2007, Game et al., 2012).  
Consequently, chronic wound management is difficult and infection recurs , often persisting 
for many years.  Infection management from the host perspective is comparably complex as 
microorganisms have evolved with their host and adapted to immune defences.  Through a 
combination of immune evasion, virulence and biofilm formation pathogens can persist 
within wounds and impair healing. 
This review will consider how the microbial community and host environment 
contribute to sustained chronic wound infection and will evaluate how novel antimicrobial 
strategies might assist in management of chronic wound infection. 
The changing host environment and onset of wound chronicity 
Wound healing is a dynamic process that can be divided into haemostasis, 
inflammation, proliferation/epithelialisation and remodelling phases (Figure 1). Acute 
wounds manifest in a variety of ways including those with considerable tissue loss, incisional 
wounds and partial thickness wounds.  In order to heal, each of these wound types follows 
the same series of complex, converging events, requiring the coordination of several cell 
types. Platelets provide the first response to wounding and neutrophils subsequently 
remove debris and bacteria.  Mast cells signal the start of the inflammatory stage, which 
involves macrophages, fibroblasts, smooth muscle cells and lymphocytes.  Post-
inflammation, fibroblast, epithelial and endothelial cells proliferate, producing factors that 
encourage angiogenesis culminating with cross-linking of collagen and scar maturation 
(Diegelmann and Evans, 2004). 
Situations can arise where healing progresses either in a deficient or excessive 
manner. An acute wound can become stalled and “stuck” in one of the four phases of the 
wound healing cycle, leading to what is referred to as a chronic or non-healing wound 
(Diegelmann and Evans, 2004). In a wound with excessive healing, contracture occurs (Inoue 
et al., 1998, Nedelec et al., 2000) which imposes stress on the wounded area and confines 
movement of the underlying tissues.  There are various types of chronic wounds classified 
by a number of factors including aetiology, morphological characteristics and level of 
microbial contamination (Figure 2). 
The chemistry of the wound bed also contributes to the propensity for chronic 
wound development.  If the inflammatory phase continues for an extended period of time 
excessive levels of inflammatory cytokines such as IL1- , IL-8 and TNF-, are achieved and 
cells in the wound bed become senescent.  Additionally, receptors on the surface of cells 
such as keratinocytes and fibroblasts are reduced in number preventing signalling by 
essential growth factors.  These include epidermal growth factor (EGF), transforming growth 
factor- (TGF-), fibroblast growth factor 2 (FGF2) and vascular endothelial growth factor 
(VEGF) (which are essential for re-epithelialisation and vascularisation of new tissues), and 
their cognate receptors EGFR (for both EGF and TGF-), FGFR and KDR, respectively (Jiang et 
al., 2014, DiPersio et al., 2016). Compounding this are excessive levels of proteases 
produced in response to abnormally high levels of TGF-; these destroy the aforementioned 
growth factors and their associated receptors, thus preventing normal repair and 
angiogenesis.  Fundamentally, the breakdown of normal wound healing can occur at any 
number of the stages outlined above which, if not appropriately ‘managed’ by the host, 
leave the wound open to contamination from skin microbiota and environmental 
microorganisms, including pathogens. 
Microbial influence on the shift to wound chronicity 
The wound repair pathways, described above, can be disrupted by microorganisms.  Even 
without clinical signs of infection, bacteria interfere with the healing process by disrupting 
critical signalling systems which result in excessive production of pro-inflammatory 
cytokines such as IL1- , IL-8 and TNF- (Seth et al., 2012a, Seth et al., 2012b). Bacterial-
derived components such as lipopolysaccharide, lipoteichoic acid, toxins and other secreted 
or surface bound effectors prompt this response using a Toll-like receptor dependent 
mechanism (Zhao et al., 2013, Ward et al., 2015, Miller, 2008) which have been documented 
for a number of wound-associated, biofilm organisms including P. aeruginosa, Klebsiella 
pneumoniae and S. aureus.  These pro-inflammatory signals initiate wound repair, cell 
migration, angiogenesis and inflammation; this is a normal response to infection, but if 
unabated maintains widespread tissue damage.   
 Recent investigations have described a scenario in which bacterial biofilm disrupts 
typical host immune responses within infected wounds, in a manner that is distinct to that 
of planktonic organisms (Thurlow et al., 2011, Nguyen et al., 2013, Ward et al., 2015, Gogoi-
Tiwari et al., 2015, Secor et al., 2011, Sadowska et al., 2013).  Predominantly, these studies 
have utilised S. aureus as a model since it is the most commonly isolated wound pathogen, 
but a few studies have focussed on P. aeruginosa, recognised as the second most common 
wound pathogen (Seth et al., 2012a, Seth et al., 2012b).  The use of mouse models to assess 
the function of TL2 and TL9 (ligands for both are present within the biofilm) indicate that 
Gram positive bacteria within a biofilm, such as Staphylococcus aureus, evade traditional 
bacterial recognition pathways therefore successfully avoiding the host immune response.  
Typical attenuation of the pro-inflammatory response includes diminished production of IL-
1β, TNF-α, CXCL2 and CCL2 (Thurlow et al., 2011).   Soluble bacterial factors mediate the 
effects described above, presumably secreted by the infecting bacteria.  Macrophages are 
also known to have impaired function and migration when biofilm is present (Donlan, 2002, 
Wolcott et al., 2008).  Significantly it has been found that macrophages associated with the 
biofilm surface are predominantly non-viable (Thurlow et al., 2011).  Movement of viable 
macrophages into the biofilm structure is also diminished and cells that permeate the 
biofilm tend to have limited phagocytic capabilities as a consequence of large matrix 
components resulting in frustrated phagocytosis which eventually causes macrophage death 
(Zhao et al., 2013, Cerca et al., 2006, Schommer et al., 2011).  In this case the effect is not 
instigated by secreted bacterial factors, but is reliant on surface-bound structures that are 
recognised by macrophages.  
 Unique, biofilm-associated protein profiles are associated with attenuation of the 
host-immune response to infection (Tankersley et al., 2014, Prabhakara et al., 2011, Kirker 
et al., 2009).  Elevated apoptosis of keratinocytes and mesenchymal stromal cells combined 
with a general reduction in viability and impaired migration is observed in response to 
biofilms of a wide genera of microorganisms including S. aureus and P. aeruginosa, which 
ultimately impedes early stage angiogenesis and consequent wound healing (Kirker et al., 
2009, Secor et al., 2011, Ward et al., 2015, Zhao et al., 2010)  It has been proposed that 
these effects are mediated by reduced cytokine expression resulting from suppressed JNK 
(c-Jun N-terminal kinases) and p38 phosphorylation (Ward et al., 2015, Secor et al., 2011).  A 
similar scenario is apparent for oral biofilm and it is conjectured that cytokines vital for 
initiating healing are degraded following biofilm contact (Fletcher et al., 1998, Guggenheim 
et al., 2009). 
 In vivo infections models incorporating medical conditions such as diabetes (which is 
associated with a high incidence of chronic ulceration of the lower limb) have modified the 
paradigms described above by inclusion of differing host characteristics (Falanga, 2005, 
Baltzis et al., 2014).  For example in a TallyHo mouse model of type 2 diabetes in which pro-
inflammatory cytokine expression is reduced, the TLR pathway for recognition of pathogens 
is impaired and re-epithelialisation disrupted (Nguyen et al., 2013).   This could in part 
explain why individuals with underlying conditions that cause immune-suppression are 
more predisposed to developing chronic infected wounds, which are likely exacerbated 
further by biofilm-mediated immune-dampening.  Despite these recent advances in the 
understanding of bacterial biofilm and its role in chronic wound infection, the relationship 
between inflammatory response and clinical infection remains difficult to define.  Currently 
bacterial bioburden remains to be the main indicator of progression towards infection 
(Grice et al., 2010).  In light of this it is imperative to understand the microbial community 
that comprises the bacterial bioburden. 
Microbial communities in the chronic wound 
The skin microbiome is comprised of four major phyla (Acinteobacteria, 
Bacteroidetes, Firmicutes and Proteobacteria) which also form a significant proportion of 
the oral and gastrointestinal microbiota (Grice and Segre, 2011).  Within these 
environments interpersonal species variation differs significantly but temporal community 
stability endures relatively unchanged.  Wounds facilitate a dramatic shift from a dry 
environment to one that is comparatively wet causing a substantial environmental 
modification which has a significant impact on the composition of the microbial community.   
 Microbiota of the skin is uniquely adapted to withstand low water availability, acidic 
pH, sloughing of the epidermis layer and enzymatic secretions such as lysozyme.  The 
majority of skin microorganisms are classified as commensals or opportunistic pathogens 
normally inhabiting the host without detriment.  Invariably, following damage to the skin 
microorganisms residing therein colonise the exposed tissues.  Much like microorganisms of 
the oral cavity, skin- and wound-associated bacteria have an abundance of surface bound 
receptors that confer upon them the ability to attach to cell-associated proteins and 
components of the extracellular matrix (Romero-Steiner et al., 1990, Darmstadt et al., 1999, 
Mempel et al., 1998, Coates et al., 2014).  
Following skin damage, non-differentiated keratinocytes and epithelial cells, and 
fibroblasts are exposed along with an abundance of ECM-associated proteins providing new 
surfaces and different ligands for bacterial attachment (Santoro and Gaudino, 2005).  
Aerobic and anaerobic members of the endogenous microbiota adhere better to 
differentiated cells indicating that a niche consisting of non-differentiated cells might be 
available for colonisation by exogenous microorganisms expressing appropriate surface 
adhesins (Romero-Steiner et al., 1990).  Several bacterial surface adhesins have been 
identified that are critical for interaction with either keratinocytes or epithelial cells of the 
skin including the Eap protein of S. aureus, which is overexpressed in situ in wounds 
(Thompson et al., 2010, Palma et al., 1999, Hussain et al., 2002), streptococcal M protein 
(Darmstadt et al., 2000, Okada et al., 1995), various fibronectin and collagen binding 
proteins and the Bap protein of Acinetobacter baumanii, which is critical for biofilm 
formation (Brossard and Campagnari, 2012).  Gram positive and Gram negative bacteria are 
covered in a plethora of surface proteins that function as adhesins.  Within the context of 
the wound environment these adhesins mediate attachment to ubiquitous host proteins 
such as collagen, fibronectin, vitronectin, elastin and laminin found on the cell surface and 
within the extracellular matrix.  Consequently, there is likely to be competition between 
colonising bacteria for attachment.  Competition for attachment sites is likely to be less 
competitive where highly specific interactions have evolved, for example between the M 
protein of Streptococcus pyogenes and CD44 on human keratinocytes. 
The application of traditional ecological theory to the human microbiome and 
infectious disease remains relatively new.  However, it is generally accepted that niche 
characteristics at the site of infection confer selective pressures responsible in part, for 
shaping the microbial community.  Numerous studies describe an archetypal model in which 
microorganisms compete for resources, resulting in the emergence of so called social 
“cheats” (Morgan et al., 2012, Harrison and Buckling, 2009).  Contrary to this is the notion 
that synergy is critical for biofilm community composition and microbial survival.  This 
advocates an alternative hypothesis in which the dynamics of the developing microbial 
community can be better described in terms of proliferation and association rather than 
selection and competition.  Significantly bacterial association is  observed during the 
development of dental plaque and the resulting community co-operation is known to be 
integral for the onset of gingivitis and tooth decay (Hajishengallis and Lamont, 2012, Filoche 
et al., 2010, Sbordone and Bortolaia, 2003, Kolenbrander et al., 2006b).  At present, 
equivalent evidence describing wound colonisation and the onset of infection, is 
insubstantial. 
Despite this, several in vivo and in vitro studies have described the basic interactions 
between several pathogens within the wound biofilm.  Molecular investigations have 
identified prominent members of the biofilm using a combination of 16S rRNA gene 
analysis, denaturing gradient gel electrophoresis, fluorescent in situ hybridisation and 
pyrosequencing (Frank et al., 2009, Wolcott et al., 2009, Dowd et al., 2008, James et al., 
2008, Kirketerp-Møller et al., 2008).  These studies have revealed typical chronic wound 
biofilms to be comprised of species of Staphylococcus, Pseudomonas, Enterobacter, 
Stenotrophomonas, Corynebacterium and Clostridium. Of these Staphylococcus is most 
prevalent, followed by Corynebacterium, Clostridium and Pseudomonas with other 
microorganisms present in lower numbers.  The bacterial species that colonise wounds tend 
to be similar between patients and irrespective of the type of wound there is an observable 
reduction in microbial diversity over time.  The latter phenomenon is evident in other types 
of chronic infection including the cystic fibrosis lung and oral cavity, suggesting a correlation 
between chronicity and diminished microbial diversity (Coburn et al., 2015, Kirst et al., 
2015).  Reduced microbial diversity within a given environment can occur as a consequence 
of successive colonisation.   Favourable environmental conditions ultimately lead to the 
emergence a small number of dominant species whose growth alters the local environment 
thus conferring a competitive growth advantage.  This model has been used to describe the 
developing oral biofilm and as a fuller understanding of wound colonisation emerges, might 
become applicable to the development of wound biofilm and management of chronic 
wound infection (Teles et al., 2012). 
Can oral microbial communities serve as a model for chronic wound infection? 
 The oral microbiome is one of the most extensively characterised human microbial 
communities.  Despite considerable diversity of species, oral biofilm development follows a 
well-defined, temporal course (Kolenbrander et al., 2006a).  The composition of healthy oral 
biofilm can change if left undisturbed, and this change can ultimately lead to gingivitis 
and/or periodontitis. Unlike the colonised wound, the initiation of periodontal disease is 
independent of a critical colonisation threshold.  Instead dysbiosis underpins the shift from 
health to disease with the predominance of anaerobic organisms serving as indicators of 
disease (Hajishengallis and Lamont, 2012, Lamont and Hajishengallis, 2015, Berezow and 
Darveau, 2011).  Typical microbial profiles associated with “normal skin microbiota” are 
sometimes observed within chronic wounds but once infection has established, these 
diminish to be replace by a few pathogenic bacteria; this is indicative of dysbiosis as 
observed in the oral cavity. Critically, the factors that initiate and continue to drive changes 
in microbial community composition and pave the way to chronic wound infection remain 
to be clarified.  As such, no temporal description of biofilm development in the chronic 
wound exists, to date, that would aid understanding of dysbiosis and the onset of disease.  
 Early plaque is characterised by the presence of cocci and short rods  of relatively 
conserved phyla.  Co-aggregation between pioneer and secondary colonisers that comprise 
these phyla is crucial and mixed-species colonies emerge within a very short space of time 
(Kolenbrander, 1988).  Cocci and rods of the genera Staphylococcus, Streptococcus, 
Propionibacterium, Corynebacterium and Acinetobacter frequently colonise the skin and 
wound-bed, where they form microcolonies.  Given their proximity to wounded or damaged 
skin, it is likely that these microorganisms serve as early or pioneer colonisers in wound 
biofilms.  At present there is little information describing specific bacterial interaction in 
wound biofilms due to a lack of suitable models.  However, understanding such processes is 
fundamental for the appropriate, targeted intervention strategies for prophylactic 
management of wound infection. 
Environmental factors play a central role in microbial population dynamics, exerting 
various selective, evolutionary pressures.  Biofilm within the oral cavity is dynamic, 
experiencing conditions of flow and regular disruption; consequently, rapid attachment and 
co-aggregation is paramount for successful colonisation.  Flow is negligible within wounds 
and is estimated at between 0.41-0.52g/cm2/24h (no infection) and 0.87-1.2g/cm2/24h 
(infected wound) (Thomas et al., 2014) far lower than that of the oral cavity (0.48ml/min) 
(Fenoll-Palomares et al., 2004).  The low to negligible flow rate within the wound suggests a 
less dynamic environment which might not select for rapid bacterial attachment and co-
aggregation.  For example, bacterial microcolonies have been observed within wounds 
within ten hours following contamination, whereas for dental plaque on freshly cleaned 
tooth surfaces, this occurs within four to eight hours (Palmer et al., 2003).  Despite this 
disparity co-aggregation to form microcolonies is an integral process for biofilm 
development for two reasons.  Firstly it mediates early attachment and microcolony 
formation at the sub-stratum; secondly it provides a competitive growth advantage to pre-
aggregated bacteria that subsequently attach to the developing biofilm (Alhede et al., 2011). 
Co-operation is evident in oral biofilms and relies on the altruistic behaviour of 
member organisms such as the streptococci who undergo lysis to release DNA which is 
incorporated as a structural component of the growing biofilm as eDNA (Liao et al., 2014, 
Klein et al., 2015).  As well as stabilising the biofilm, eDNA also has an important role in 
horizontal gene transfer.  Whilst this seemingly altruistic behaviour is not unique to biofilms 
of the oral cavity, no reports have described this phenomenon within the wound biofilm.  
However, given the ubiquity of eDNA as a scaffold molecule within biofilms and its 
observation within single-species biofilms of P. aeruginosa and S. aureus, it is not 
unreasonable to hypothesise that eDNA forms an integral component of wound biofilms.  A 
growing body of evidence indicates synergy of virulence between members of wound 
biofilms including S. aureus and P. aeruginosa.  For example S. aureus is known to enhance 
the growth of host adapted strains of P. aeruginosa and promotes an S. aureus small colony 
variant phenotype (Mitchell et al., 2010, Mashburn et al., 2005b).  Additionally P. 
aeruginosa is known to utilise S. aureus as a source of iron and can also promote the 
expression of S. aureus virulence factors such as Panton-Valentine leucocidin (Mashburn et 
al., 2005a, Pastar et al., 2013).  Therefore, early co-operation in addition to eventual 
dysbiosis is a fundamental consideration for chronic wound management. 
Despite much being understood about the bacterial interactions within oral biofilm 
communities, at present not enough is understood about chronic wound biofilm 
communities for these models to be applied as a means of describing the ecology of the 
chronic infected wound.  However, this breadth of knowledge can be used to inform and 
build accurate models of chronic wound infection. A wider theoretical template for biofilm 
development in chronic wounds that takes into consideration the shift from healthy 
colonisation to disease, has the potential to be clinically useful.   For example, 
understanding temporal biofilm development with regards to specific bacterial interactions 
could inform appropriate, timely intervention where clinical infection is apparent but 
laboratory diagnosis is not yet confirmed.  In short it could allow the clinician to intervene to 
prevent secondary infection and make better decisions about topical wound treatments 
which are pertinent to chronic wound management.  For a fuller review of the application of 
knowledge gleaned from the study of oral biofilms, to wound biofilms the reader is directed 
to Mancl et al., 2013.   
Managing chronic wound infection with antimicrobials 
In the UK topical antibiotics are not usually utilised for the treatment of wound infection 
and systemic antibiotic treatments are not routinely administered due to problems 
associated with targeting of treatments to the site of infection.  However, for severe 
recurrent infection with associated biofilm current guidelines support the extended use of 
high dose, orally administered antibiotics which still has limited success (Hoiby et al., 2015).  
Consequently, antiseptics are still a front-line solution applied in the form of creams or 
ointments, or impregnated into wound dressings (www.cochrane.org).  Regardless of this 
many antimicrobial treatments remain ineffectual resulting in more drastic strategies such 
as submersion in potassium permanganate, hydrogen peroxide or bleaches as a last resort 
prior to life-changing procedures such as amputation (Wounds International, 2008). 
 Topical treatments often do not resolve chronic wound infection because they 
diffuse poorly through the wound-bed and extracellular polysaccharide layer of the biofilm 
and therefore do not reach all infectious organisms.  This consequently results in the 
establishment of concentration gradients which expose microorganisms deep within the 
biofilm to sub-lethal doses of antimicrobial treatment, imparting a selective evolutionary 
pressure that favours the emergence of resistant phenotypes (Percival et al., 2011).  
Therefore, following completion of antimicrobial treatment infection often recurs.  To 
counter these problems numerous novel strategies have been developed to ensure 
appropriate delivery of efficacious treatments that do not promote antimicrobial resistance.  
Many of these are currently not available to medical practitioners and remain in the early 
stages of development. 
 Attractive alternatives to traditional antimicrobial treatments include quorum 
sensing inhibitors (Njoroge and Sperandio, 2009), anti-biofilm/anti-adhesive (Rabin et al., 
2015) or anti-virulence compounds (Stubben et al., 2009), nano-formulated antimicrobials 
(Neethirajan et al., 2014) and combination therapies drawn from natural products including 
phenolic compounds and flavonoids (Borges et al., 2015).  The appeal of many of these 
therapies is their ability to attenuate virulence, which does not impose traditional “survival 
of the fittest” pressures upon the microbial population.  With regards to biofilm associated 
infection such as chronic wound infection, anti-biofilm/anti-adhesive strategies could 
provide an effective solution.    
A growing number of varied compounds demonstrate anti-biofilm activity.  Of 
particular note is an emerging family of cationic antimicrobial peptides with poor microbial 
killing but good anti-biofilm activity, being especially effective at penetrating and dispersing 
established or mature biofilms (Park et al., 2011).  Specific amino acid motifs (FRIRVRV) 
associated with anti-biofilm property, have been identified.   Although their precise function 
remains to be determined these peptides impair swimming, twitching and swarming 
motility in P. aeruginosa as well as supressing the expression of genes involved in biofilm 
formation (Xu et al., 2014).  This knowledge provides a basis for the synthesis of targeted 
anti-biofilm peptides and given that several cationic anti-microbial peptides are currently 
licenced for medical use; they represent a tangible alternative treatment for biofilm 
infection in wounds. 
 Jamming microbial communication can also impair biofilm development and 
attenuate virulence.  The majority of quorum sensing inhibitors that have so far been 
developed rely on P. aeruginosa a model system and are therefore more applicable to 
control of infection by Gram negative bacteria (Starkey et al., 2014).  However early analysis 
of peptide quorum sensing molecules derived from Gram positive bacteria indicate that this 
strategy could be more broadly applied.  Significantly it is possible to impair the autoinducer 
three system, in vitro (Rasko et al., 2008). The autoinducer three quorum sensing system is 
necessary for inter-species bacterial signalling and therefore might prove effective for 
impairing the development of polymicrobial communities .  But more specifically, studies 
using E. coli have indicated the involvement of QseC (which is part of the autoinducer three 
system conserved in Gram negative bacteria), also responds to human catecholamine 
hormones which results in attenuated virulence (Rasko et al., 2008).  Anti-biofilm and 
quorum-sensing inhibition are both strategies that rely on disruption of the microbial 
community, impeding their interactions with the host to promote clearance of infection 
rather than mediating bacterial death. 
 In recent years there has been significant focus on natural products as a source of 
novel antimicrobial compounds.  Plant derivatives are rich in anti-oxidants, flavonoids and 
polyphenols all of which are known to impair bacterial growth (Savoia, 2012).  Despite 
numerous studies which have isolated and identified individual antimicrobial compounds 
from these sources, it is generally believed that the antimicrobial efficacy of natural 
products can be attributed to the combined activity of different components , similar to the 
hurdle technologies utilised for microbial control within the food industry.  Whilst natural 
products offer an alternative route to identify new antimicrobials beyond synthetic 
chemistry, they ultimately impose the same selective pressures as traditional antimicrobials 
and equivalent challenges with regards to effective delivery.  Within the multitude of 
emerging natural antimicrobial treatments, several with anti-biofilm or anti-virulence 
properties have been identified.  These properties are often only evident at sub-lethal doses 
and appear secondary to bacterial lysis or impaired growth.  Consequently, using such 
compounds at levels that impart non-lethal mechanisms of infection control could inevitably 
result in resistance in the long term. 
 Novel delivery systems have tried to overcome problems associated with 
antimicrobial delivery and nano-formulation is a promising strategy.  Nano-formulated 
antimicrobials do not necessarily have a different mode of action but when incorporated 
into antimicrobial wound dressings or polymers, for example have a slower and therefore 
prolonged rate of release therefore ensuring a steady dose over an appropriate time frame 
to resolve infection (Zhang et al., 2010).  The versatility of nano-formulated antimicrobial 
means they can be incorporated into a large variety of different materials from wound 
dressings to polymers and dental materials (Hook et al., 2014, Wood et al., 2014, Barbour et 
al., 2013).  However, the disadvantage is that antimicrobial nano-particles have so far 
utilised bactericidal compounds such as silver or chlorhexidine, which does not counter 
problems associated with antimicrobial resistance.  Despite this promising research has 
revealed that peptides can be packaged into nano-structures which allow for topical delivery 
(Bi et al., 2011).  With regards to chronic wound infection, this would allow peptides to be 
delivered to the site of infection, and could be adapted to utilise novel antimicrobial 
peptides, such as those with anti-biofilm activity.  Furthermore, hydrogels developed 
specifically for chronic wound treatment, can be loaded with nanoparticles for efficacious 
delivery to the wound site whilst maintaining an environment that is conducive to wound 
healing (Villanueva et al., 2016, Das et al., 2015, Ng et al., 2014). 
 Despite an apparent abundance of newly explored and emerging antimicrobial 
treatments, managing chronic infected wounds still remains a challenge.  A variety of 
treatments are relied upon for the management of chronic wound infection and where 
traditional antimicrobials fail combined strategies are utilised that include wound cleaning, 
surgical debridement and in the most severe cases, amputation.  Given the extreme, 
sometimes life-changing nature of interventions such as these, the drive to identify and 
develop alternate efficacious chronic wound management strategies is vital. 
Summary and conclusions 
Two contrasting hypotheses describe the chronic wound scenario.  The first purporting that 
biofilm within the wound impairs healing and the second that the host is the cause of 
delayed wound healing with the development of biofilm being a natural consequence of the 
failure to re-epithelialize in a timely manner.  If chronic infected wounds are to be managed 
appropriately and effectively these concepts must not be considered as mutually exclusive.  
Therefore, understanding host-pathogen interactions during chronic wound infection is 
essential to enable knowledge about the development and treatment of chronic infected 
wounds to be translated into palpable clinical interventions. 
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